Cancer Surgery
Open Access

Brain Cancer; Immunotherapy; Medulloblastomas

Introduction

Brain cancer refers to the abnormal growth of cells within the brain or its surrounding tissues. These tumors can be either benign (non-cancerous) or malignant (cancerous). Malignant brain tumors are considered more severe as they tend to invade surrounding healthy tissues and can spread to other parts of the body [1].The exact causes of brain cancer are not fully understood. However, certain factors may increase the risk of developing this condition. These include exposure to ionizing radiation, family history of brain tumors, genetic syndromes, immune system disorders, and certain environmental toxins. Nonetheless, it is essential to note that brain cancer can affect anyone, regardless of these risk factors [2-5].

Brain cancer can be categorized into two main groups: primary brain tumors and secondary brain tumors. Primary brain tumors originate within the brain itself, while secondary brain tumors, also known as metastatic brain tumors, occur when cancer cells spread to the brain from other parts of the body. Primary brain tumors are further classified based on the type of cells they originate from, such as gliomas, meningiomas, pituitary tumors, and medulloblastomas [6,7].

Brain cancer symptoms vary depending on the tumor's size, location, and rate of growth. Common signs may include persistent headaches, seizures, vision or hearing problems, difficulty speaking or understanding language, personality changes, memory loss, and balance issues. If brain cancer is suspected, diagnostic tests such as MRI scans, CT scans, PET scans, and biopsies are conducted to confirm the presence of a tumor and determine its characteristics [8].

Material and Methods

The treatment of brain cancer requires a multidisciplinary approach, involving a team of specialists including neurosurgeons, oncologists, radiation oncologists, and supportive care professionals. The treatment plan depends on factors such as the tumor type, size, location, and the patient's overall health. Common treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and supportive care to manage symptoms and enhance the quality of life.

The quest for improved brain cancer treatments continues. Researchers are exploring novel approaches such as immunotherapies, precision medicine, and gene therapies to target specific genetic mutations in brain tumours. Advances in imaging technologies such as molecular imaging and liquid biopsies offer new avenues for early detection and personalized treatment. Additionally, clinical trials provide hope for patients by testing new drugs and treatment strategies that may lead to breakthroughs in the field [9,10].

Living with brain cancer is a challenging journey that affects not only patients but also their caregivers and loved ones. It is crucial to provide emotional support, access to counselling services, and resources that address the unique needs of those impacted by brain cancer. Support groups, patient advocacy organizations, and online communities can offer valuable guidance, comfort, and a sense of belonging during this difficult time.

Conclusion

Brain cancer presents a formidable medical challenge, demanding a comprehensive understanding of its intricacies and relentless pursuit of effective treatments. As researchers, medical professionals, and the global community unite their efforts, progress is being made in unraveling the mysteries of brain cancer. With continued research, advancements in early detection, personalized therapies, and improved Brain cancer, an intricate and devastating disease, poses significant challenges in the medical field. In this article, we explore the causes, types, symptoms, diagnosis, treatment options, and ongoing research in the realm of brain cancer, shedding light on this formidable adversary that affects millions of lives worldwide.

1. Osborne M P (2007) William Stewart Halsted: His life and contributions to surgery. Lancet On col 8: 256-265.

Indexed at, Google Scholar, Crossref

2. Fisher B (1977) United States trials of conservative surgery. World J Surg 1: 327-330.

Indexed at, Google Scholar, Crossref

3. Turnbull RB Jr, Kyle K, Watson FR, Spratt J (1967) Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann Surg166: 420-427.

Indexed at, Google Scholar, Crossref

4. Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg69:613-616.

Indexed at, Google Scholar, Crossref

5. Søndenaa K, Quirke P, Hohenberger W, Sugihara K, Kobayashi H, et al.( 2014) The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery. Proceedings of a consensus conference Int J Colorectal Dis 29: 419-428.

Indexed at, Google Scholar, Crossref

6. Klotz R, Hackert T, Heger P, Probst P, Hinz U, et al. (2021) The TRIANGLE operation for pancreatic head and body cancers: Early postoperative outcomes. HPB (Oxford)

Indexed at, Google Scholar, Crossref

7. Dogan NU, Dogan S, Favero G, Köhler C, Dursun P, et al. (2019) The Basics of Sentinel Lymph Node Biopsy: Anatomical and Pathophysiological Considerations and Clinical Aspects. J. Oncol.2019:3415630.

Indexed at, Google Scholar, Crossref

8. Deijen CL, Vasmel JE, de Lange-de Klerk ESM, Cuesta MA, Coene PLO, et al.( 2017) Ten-year outcomes of a randomised trial of laparoscopic versus open surgery for colon cancer. Surg. Endosc. 31: 2607-2615.

Indexed at, Google Scholar, Crossref

9. Straatman J, Cuesta MA, Daams F, Roig Garcia J, Bonavina L, et al.( 2017) Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: The TIME Trial. Ann. Surg. 266:232-236.

Indexed at, Google Scholar, Crossref

10. Vennix S, Pelzers L, Bouvy N, Beets GL, Pierie JP, et al. (2014) Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst. Rev: Cd005200.

Indexed at, Google Scholar, Crossref